Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $12.8M | 84 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Beckman Coulter, Inc. | $12.3M | 10 | $0 (2024) |
| Becton, Dickinson and Company | $468,239 | 74 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2.4M | 18 | Beckman Coulter, Inc. ($2.2M) |
| 2023 | $2.8M | 15 | Beckman Coulter, Inc. ($2.6M) |
| 2022 | $2.7M | 18 | Beckman Coulter, Inc. ($2.6M) |
| 2021 | $2.5M | 17 | Beckman Coulter, Inc. ($2.5M) |
| 2020 | $2.4M | 16 | Beckman Coulter, Inc. ($2.4M) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $19,675.53 | General |
| Category: Reagents | ||||||
| 10/25/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $15,680.09 | General |
| Category: Reagents | ||||||
| 10/25/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $445.99 | General |
| Category: Reagents | ||||||
| 10/25/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $42.32 | General |
| Category: Reagents | ||||||
| 07/25/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $19,904.29 | General |
| Category: Reagents | ||||||
| 07/25/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $15,986.40 | General |
| Category: Reagents | ||||||
| 07/25/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $1,319.88 | General |
| Category: Reagents | ||||||
| 07/25/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $18.00 | General |
| Category: Reagents | ||||||
| 04/26/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $14,105.39 | General |
| Category: Reagents | ||||||
| 04/26/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $12,044.22 | General |
| Category: Reagents | ||||||
| 04/26/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $154.03 | General |
| Category: Reagents | ||||||
| 04/26/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $13.54 | General |
| Category: Reagents | ||||||
| 04/08/2024 | Beckman Coulter, Inc. | NAVIOS (Device), Cytomics FC500, AQUIOS | Royalty or License | Cash or cash equivalent | $1,912,453.10 | General |
| Category: Devices | ||||||
| 04/02/2024 | Beckman Coulter, Inc. | AQUIOS (Device), NAVIOS, Cytomics FC500 | Royalty or License | Cash or cash equivalent | $330,203.53 | General |
| Category: Devices | ||||||
| 01/25/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $12,096.45 | General |
| Category: Reagents | ||||||
| 01/25/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $10,584.89 | General |
| Category: Reagents | ||||||
| 01/25/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $1,449.72 | General |
| Category: Reagents | ||||||
| 01/25/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $16.80 | General |
| Category: Reagents | ||||||
| 10/25/2023 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $16,898.45 | General |
| Category: Reagents | ||||||
| 10/25/2023 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $14,497.94 | General |
| Category: Reagents | ||||||
| 10/25/2023 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $442.50 | General |
| Category: Reagents | ||||||
| 07/24/2023 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $16,136.32 | General |
| Category: Reagents | ||||||
| 07/24/2023 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $12,982.83 | General |
| Category: Reagents | ||||||
| 07/24/2023 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $941.82 | General |
| Category: Reagents | ||||||
| 06/20/2023 | Beckman Coulter, Inc. | Cytomics FC500 (Device), NAVIOS, AQUIOS | Royalty or License | Cash or cash equivalent | $2,325,766.83 | General |
| Category: Devices | ||||||
About Dr. John Pesando, MD
Dr. John Pesando, MD is a Hematology & Oncology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2020. The National Provider Identifier (NPI) number assigned to this provider is 1477150969.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Pesando, MD has received a total of $12.8M in payments from pharmaceutical and medical device companies, with $2.4M received in 2024. These payments were reported across 84 transactions from 2 companies. The most common payment nature is "Royalty or License" ($12.8M).
Practice Information
- Specialty Hematology & Oncology
- Location Seattle, WA
- Active Since 10/07/2020
- Last Updated 10/07/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477150969
Products in Payments
- NAVIOS (Device) $6.6M
- Cytomics FC500 (Device) $2.6M
- FC 500 SERIES (Device) $2.2M
- CYTOFLEX (Device) $617,470
- AQUIOS (Device) $330,204
- Horizon (Device) $234,086
- BD Pharmingen (Device) $120,867
- FACSVia (Device) $27,555
- BD OptiBuild (Device) $22,629
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Seattle
John Pagel, Md Phd, MD PHD
Hematology & Oncology — Payments: $1.3M
Dr. Langdon Miller, Md, MD
Hematology & Oncology — Payments: $674,815
Dr. Vijayakrishna Gadi, M.d. Phd, M.D. PHD
Hematology & Oncology — Payments: $534,649
Barbara Konkle, Md, MD
Hematology & Oncology — Payments: $331,390
Dr. Jill Johnsen, Md, MD
Hematology & Oncology — Payments: $291,732
Dr. Rebecca Kruse-Jarres, M.d, M.D
Hematology & Oncology — Payments: $288,284